Research by GlobalData reveals top pharmaceutical companies' commitments to Net Zero strategies, reducing Scope 1 and 2 emissions successfully. Challenges remain in addressing Scope 3 emissions and integrating sustainability with industry trends like automation and AI.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing